Excelra, HotSpot Therapeutics partner on drug discovery

By The Science Advisory Board staff writers

May 26, 2022 -- Excelra is partnering with HotSpot Therapeutics to further the discovery and development of small molecule therapy candidates directed toward allosteric targets that have been difficult to treat, or untreatable, with traditional small molecule approaches.

HotSpot Therapeutics will use data from Excelra's flagship product Global Online Structure Activity Relationship (GOSTAR) database with its machine learning and artificial intelligence models to accelerate both hit identification and chemical diversification in the field of allostery, according to Excelra.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.